Healthstream (HSTM) Current Deferred Revenue (2010 - 2026)

Healthstream (HSTM) has 17 years of Current Deferred Revenue data on file, last reported at $106.4 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue rose 4.31% year-over-year to $106.4 million in Q1 2026; TTM through Mar 2026 was $106.4 million, a 4.31% increase from a year earlier, with the FY2025 full-year figure at $88.4 million, up 4.97% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $106.4 million, up from $88.4 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for HSTM reached as high as $106.4 million in Q1 2026 and fell as low as $77.6 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $87.9 million across 5 years, with a median of $85.7 million in 2025.
• Across the five-year window, Current Deferred Revenue gained 7.66% in 2022 and dropped 0.34% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $79.5 million in 2022, then gained by 5.23% to $83.6 million in 2023, then advanced by 0.72% to $84.2 million in 2024, then increased by 4.97% to $88.4 million in 2025, then rose by 20.34% to $106.4 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $106.4 million in Q1 2026, $88.4 million in Q4 2025, and $85.7 million in Q3 2025.